How a small retina implant is helping people regain sight

A new study in The New England Journal of Medicine revealed that the PRIMA brain-computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some central vision. The device uses a small 2 millimeter by 2 millimeter photovoltaic implant that is only 30 micrometers thick and thinner than a strand of hair. It sits under the retina and works with a special pair of smart glasses. The glasses capture images and send them in the form of near-infrared light to the implant. The implant converts that light into small electrical signals that stimulate the optic nerve. This process mimics how healthy retinal cells normally send visual information to the brain.

The study followed 38 participants, 32 of whom completed one year of follow-up. Twenty-six patients experienced a measurable improvement in vision, equal to approximately 80% of the group. Many participants were able to reread letters, numbers, and even entire pages of text. Although the restored vision is black and white and slightly blurry, the results are remarkable for people who once believed they would never see clearly again.

THE WORLD’S THINEST AI GLASSES FEATURE BUILT-IN AI ASSISTANT

Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered right to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.

Why this is important for AMD treatment

Age-related macular degeneration, often called AMD, is a leading cause of irreversible blindness in older adults. Until now, available treatments could only stop vision loss. None of them could restore what had already been lost.

The PRIMA implant takes a different approach. It directly replaces the missing function of the retina by converting light into electrical signals. Patients can still use their natural peripheral vision while the implant restores some central vision. This combination creates a more complete viewing experience.

The trial showed that the surgery is generally safe. Most side effects occurred within the first two months and disappeared shortly after. Importantly, the implant did not reduce the patients’ remaining natural peripheral vision. Researchers consider this an important step toward restoring vision rather than just slowing its deterioration.

The PRIMA implant was developed by Science Corporation, a brain-computer interface company founded by Max Hodak, who previously co-founded Neuralink. Science Corporation acquired PRIMA technology from French firm Pixium Vision, continuing its development toward clinical use.

EYE DROPS CAN REPLACE READING GLASSES FOR THOSE FIGHTING AGE-RELATED VISION LOSS

What does this mean to you?

If you or a loved one is living with late-stage AMD, this breakthrough may offer real hope. For the first time, there is a device that can restore some vision instead of just preserving what’s left. You may want to talk to your ophthalmologist about upcoming trials or future approval of the PRIMA system in your area. The company behind the technology has already applied for European approval and a process is underway with the US Food and Drug Administration.

Recovering even partial central vision can make a big difference. Reading text, recognizing faces or simply moving independently is possible again. This progress also shows how quickly medical innovation is advancing. Patients who were once told nothing could help will soon have the chance to see again.

It’s also a reminder to stay informed. Treatments that were once experimental are becoming available sooner than expected. Discussing new technologies with your doctor will help you understand timing, eligibility, and what kind of results you can realistically expect.

Take my quiz: How safe is your online security?

Do you think your devices and data are really protected? Take this quick quiz to see where you stand digitally. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing well and what you need to improve. Take my quiz here: CyberGuy.com.

CLICK HERE TO DOWNLOAD THE News APP

Kurt’s Key Takeaways

The PRIMA retina implant represents a change in the way scientists and doctors think about blindness caused by AMD. For decades, the focus was on curbing the disease. Now, researchers are showing that restoration is possible. While this generation of the implant provides limited black and white vision, it provides real, functional vision to people who did not have it. That alone changes lives. There is still work to be done to improve image clarity, color perception and comfort. Still, this is just the beginning. Future versions of the device and smart glasses may make vision restoration even more effective and accessible.

If you could regain even some of your sight through new technology, would you take the opportunity and experience the world in a completely new way? Let us know by writing to us at CyberGuy.com.

Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered right to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.

Copyright 2025 CyberGuy.com. All rights reserved.